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Aims The aim of this study was to compare nationwide incidence rate (IR) of sudden cardiac death (SCD) in persons
aged 1–49 years with and without diabetes mellitus (DM).
...................................................................................................................................................................................................
Methods
and results
The study population consisted of all persons in Denmark aged 1–49 years in 2000–09, which equals 27.1 million
person-years. All 14 294 deaths in the 10-year period were included. By using the highly descriptive Danish death
certificates, 1698 cases of sudden and unexpected death were identified. Through review of autopsy reports, dis-
charge summaries, and the Danish registries, we identified 1363 cases of SCD. The Danish Register of Medicinal
Product Statistics was used to identify persons with type 1 DM and type 2 DM. Among the 14 294 decedents,
there were 669 with DM, of which 118 suffered SCD (9% of all SCD), making SCD the leading cause of death
among young persons with DM. Among those aged 1–35 years, the IR of SCD-DM was 21.9 per 100 000 person-
years compared to 2.6 per 100 000 person-years among persons without DM [IR ratio 8.6, 95% confidence interval
(CI) 5.8–28.6]. Within the age range 36–49 years, the IR among persons with DM was 119.8 per 100 000 person-
years compared to 19.7 per 100 000 person-years among persons without DM (IR ratio 6.1, 95% CI 4.7–7.8).
...................................................................................................................................................................................................
Conclusion We found that young persons with DM aged 1–35 years had >8-fold higher SCD IR compared to young persons without
DM. Our study highlights the need for early cardiovascular risk monitoring and assessment in young persons with DM.
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Introduction
Diabetes mellitus (DM) is one of the most common chronic diseases
in the young.1 Persons with DM have increased all-cause mortality
compared to the general population.1–5 The decreased life
expectancy is in part explained by an increased risk of cardiovascular
disease and sudden cardiac death (SCD) among patients with DM
(SCD-DM).1–3,5–9
Diabetes mellitus is a well-established risk factor of SCD and sev-
eral mechanisms have been proposed to account for the increased
* Corresponding author. Tel: þ45 60 45 44 13, Fax: þ45 35 45 65 00, Email: jespersvane@gmail.com
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risk of SCD among persons with DM.2,5,6 These include manifest and
silent myocardial ischaemia, QT interval prolongation, hypogly-
caemia, diabetic cardiomyopathy, and decreased ventilatory response
to hypoxia and hypercapnia.5 Increased arrhythmogenic potential,
occurring as a result of diabetes-related autonomic neuropathy may
be another contributing factor.5 Previous studies report a two- to
four-fold increased risk of SCD in persons with DM after adjustment
for cardiovascular risk factors.2,6,7,9 However, these studies do not in-
clude young persons or are based on findings from one region of a
country with data almost exclusively obtained from autopsied dece-
dents. As autopsy is far from always conducted, there is a potential
bias in the reported results. Furthermore, information on differences
in risk of SCD between persons with DM type 1 (DM1) and 2 (DM2)
is scarce.5
We have previously identified and characterized all SCD cases in
Denmark among persons aged 1–35 years in 2000–09 and 36–
49 years in 2007–09.10,11 The aim of this study was to use this unique
dataset together with information from the Danish nationwide health
registries to examine incidence rates (IRs) and underlying causes of
SCD in persons with DM aged 1–49 years. Furthermore, we aimed
to explore any differences between persons with DM1 and DM2.
Methods
In this Danish nationwide population-based study, we included all deaths
in persons aged 1–35 years in 2000–09 and 36–49 years in 2007–09.10,11
Autopsy reports, discharge summaries, death certificates, and information
from nationwide Danish health registries were used to identify all persons
with diabetes who suffered SCD.
The Danish health care system and Danish
registries
All Danish residents are assigned a unique and personal Civil Registration
Number, which can be linked to national registries on an individual level.
Information on prior medicinal usage can be retrieved from the Danish
Register of Medicinal Product Statistics, which holds information on all
prescriptions dispensed from Danish pharmacies since 1995. Prescribed
drugs are coded according to the international Anatomical Therapeutic
Chemical (ATC) classification system. Drug expenses are partially reim-
bursed by health care authorities and therefore Danish pharmacies are
required to register all dispensed prescriptions, which ensures complete
registration.12
Information on prior medical history can be retrieved from the Danish
National Patient Register which contains information on all inpatient
activities at Danish hospitals and emergency departments since 1977 (and
outpatient contacts since 1995) using ICD diagnosis codes for each visit.
Death certificates and forensic and clinical
autopsy
Whenever a person dies in Denmark a death certificate is issued. The
death certificate is always issued by a medical doctor, who on basis on all
available information, including medical files, determines most likely cause
of death. Police involvement is mandatory whenever a person is found
dead and/or death is sudden and unexpected. The police decide whether
a medicolegal external examination is performed. The police carry out
this examination together with a Medical Doctor of Public Health who
has access to first responder records, any medical files related to the
deceased, the entire police record including eye witness statements, and
the body of the deceased, which is always externally examined.
Information from all of these sources is included in a supplementary infor-
mation field on the death certificate, which makes Danish death certifi-
cates highly suitable for identification of sudden and unexpected
death.10,11
Forensic autopsy is conducted if manner of death is not fully elucidated
after medicolegal external examination. When indicated a toxicological
examination is performed by the forensic toxicology department.13
Furthermore, physicians and relatives of the deceased can request a hos-
pital autopsy if it is decided not to perform a forensic autopsy.
Study population and data collection
We have previously used the highly informative Danish death certificates
to identify sudden deaths in Denmark among all individuals aged
1–35 years in 2000–09 and 36–49 years in 2007–09.10,11
Cases of sudden and unexpected death due to cardiac causes, i.e.
SCD, were subsequently identified using autopsy reports, the Danish
National Patient Register, discharge summaries, and in selected cases
medical records. Persons with DM requiring glucose-lowering pharmaco-
therapy were identified using information from the Danish Register of
Medicinal Product Statistics.
Definitions
Sudden death was defined as a sudden, natural, unexpected death; in wit-
nessed cases, as an acute change in cardiovascular status with time to
death being <1 h and, in unwitnessed cases, as a person last seen alive and
normally functioning <24 h before being found death.
Sudden cardiac death in autopsied cases was defined as a sudden death
of unknown (sudden arrhythmic death syndrome, SADS) or cardiac
cause and in non-autopsied cases as a sudden death presumed to be of
cardiac origin after review of all available information. Non-SCD was
defined as death of either confirmed or likely cardiac aetiology, where cri-
teria of being sudden and unexpected were not fulfilled.
Among the deceased a person was defined as having DM if this person
had claimed >_1 prescription of glucose-lowering drugs (ATC A10) within
180 days of death. In the background study population, the proportion of
persons with DM was identified on an annual basis as all persons claiming
>_1 prescription of glucose-lowering drugs within 180 days of January 1.14
For both deceased and the background population, persons who at any
point in their life redeemed prescriptions of oral antidiabetic agents (ATC
A10B) ± insulin or insulin-analogues (ATC A10A) were defined as per-
sons with DM2. Those who only claimed prescriptions of insulin or
insulin-analogues were defined as persons with DM1. Due to very few
events among children and young adults, mortality patterns among per-
sons with DM2 were analysed only for persons aged 21–49 years. For
DM1, all persons aged 1–49 years were included in the analyses.
Use of QT-prolonging medicine was identified as persons that claimed
prescription <_90 days before death of a drug that prolongs the QT inter-
val according to the Credible Meds website.15
Statistical methods
Data analysis was performed using SAS software package 9.4. Incidence
rate was stratified by age and sex or calculated by direct age- and sex-
standardization. For direct standardization, 5-year age- and sex-specific
mortality rates were applied to the equivalent age and sex strata from the
general Danish population calculated as the average population in
Denmark from 2000 to 2009. Incidence rate of SCD for persons with
DM was calculated using the sex- and age-specific diabetic background
population as denominator. Incidence rate for persons without DM were
2700 T.H. Lynge et al.
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calculated with non-diabetic population of Danes as the reference popu-
lation. Exact confidence intervals (CIs) for age- and sex-specific rates
were calculated assuming Poisson distributed data. Directly standardized
IRs of SCD were also computed. Differences in proportions were tested
with the Fisher’s exact test. Continuous variables were compared using
medians and the Wilcoxon rank-sum test. Logistic regression was used to
compare SCD in persons with and without DM and to examine associa-
tions between SCD-DM and prehospital factors, comorbidities, and post-
mortem examination. Covariates for the multivariable model were
selected on basis of the univariate analysis presented in Table 1.
Results
The mean population of Danish residents aged 1–35 years in 2000–
09 and 36–49 years in 2007–09, were 2.37 and 1.11 million inhabi-
tants, respectively. This corresponds to 27.1 million person-years in
the 10-year period. There was a total of 14 294 deaths, of which
1363 (10%) suffered SCD (Figure 1). Among the 14 294 decedents,
there were 669 (5% of all deaths) with DM, of which 118
suffered SCD (9% of all SCD); 71 (60%) with DM1 and 47 (40%) with
DM2.
Clinical characteristics
A comparison of clinical characteristics between SCD cases with and
without DM is shown in Table 1. Among persons who suffered SCD
those with DM were older than persons without DM (median age 43
and 37, respectively, P < 0.001). The SCD-DM population had a sig-
nificantly higher prevalence of cardiovascular diseases compared to
the non-DM SCD population (P < 0.001). In total, 30 (25%) SCD-DM
cases claimed prescriptions of proarrhythmic pharmacotherapy with-
in 90 days of death.
Of all deaths in the study period, medicolegal external examination
and autopsy were performed in 32% and 33%, respectively. Both
medicolegal external examinations and autopsies were less frequent-
ly conducted among SCD cases with DM compared to SCD cases
without DM (50% vs. 76% and 32% vs. 57%, respectively, P < 0.001).
In a multivariable analysis comparing SCD in persons with and with-
out DM, both medicolegal external examination and autopsy was
....................................................................................................................................................................................................................
Table 1 Clinical characteristics in sudden cardiac death cases among persons with and without diabetes mellitus aged
1–35 years in 2000–09 and 36–49 years in 2007–09
Clinical characteristics SCD with DM
(n 5 118)
SCD without DM
(n 5 1245)
P-valuea
Age (years), median (IQR) 43 (35–47) 37 (29–45) <0.001
Males, n (%) 84 (71) 891 (72) 0.930
Previous medical history, n (%)
Psychiatric disease 31 (26) 266 (21) 0.217
Cardiovascular disease 32 (27) 191 (15) <0.001
Ischaemic heart disease 22 (19) 98 (8) <0.001
Heart failure 25 (21) 89 (7) <0.001
Cardiac arrhythmia 11 (9) 74 (6) 0.147
Neurological disorders 12 (10) 168 (13) 0.308
Gastrointestinal disease 10 (8) 59 (5) 0.077
Cerebrovascular disease 6 (5) 43 (3) 0.363
Medicolegal external examinationb, n (%) 55 (50) 912 (76) <0.001
Witnessed deathsc, n (%) 38 (40) 447 (40) 0.939
Autopsied SCD, n (%) 38 (32) 715 (57) <0.001
Explained SCD 28 (74) 454 (63) 0.202
SADS 10 (26) 261 (37)
Place of cardiac arrest, n (%)
Home 72 (61) 773 (62)
Public place 19 (16) 278 (22)
0.086
Hospital/ambulance 16 (14) 132 (11)
Other 11 (9) 62 (5)
Activity prior to cardiac arrest, n (%)
Awake and relaxed 45 (38) 551 (44)
Sleep 22 (19) 320 (26)
<0.001
Physical activity 3 (3) 93 (7)
Other 48 (41) 281 (23)
DM, diabetes mellitus; IQR, interquartile range; SADS, sudden arrhythmic death syndrome; SCD, sudden cardiac death.
aP-value for differences between sudden cardiac death cases with and without diabetes mellitus.
bData missing in 4% of all sudden cardiac deaths.
cData missing in 11% of all sudden cardiac deaths.
SCD among young persons with diabetes 2701
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..conducted less frequently among SCD-DM cases independent of age
and cardiac comorbidity. Age and a diagnosis of heart failure were
also independently associated with SCD-DM.
Cause of death among persons with
diabetes mellitus
An overview of causes of death among the 669 deceased with DM is
shown in Figure 2. The most common causes of death were SCD
(n = 118, 18%), non-SCD (n = 112, 17%), pulmonary disease (n = 96,
14%), and endocrine disease (n = 87, 13%). Diabetic ketoacidosis was
the most common underlying endocrine cause of death (n = 24, 28%
of all endocrine causes of death) followed by diabetic nephropathy
(n = 10, 11%) and hypoglycaemia (n = 5, 6%).
Of 38 autopsied SCD-DM cases the most frequent underlying
causes of SCD were coronary artery disease (n = 18, 47%), SADS
(n = 10, 26%), and hypertrophic heart (n = 4, 11%). Of the 10 SADS
cases, 6 had DM1 and were found dead-in-bed. In 17 (45%) of the
autopsied SCD-DM cases, cause of death was a potentially inherited
heart disease (e.g. SADS and cardiomyopathy). Among SCD-DM
Figure 1 Flowchart of the identification of all sudden cardiac deaths among patients with diabetes mellitus aged 1–35 years in 2000–09 and
36–49 years in 2007–09. DM, diabetes mellitus; SCD, sudden cardiac death.
Figure 2 Causes of death among deceased persons with diabetes aged 1–35 years in 2000–09 and 36–49 years in 2007–09 (n = 669). CVD, cardio-
vascular disease; SCD, sudden cardiac death. P-values are for differences between persons with type 1 and 2 diabetes.
2702 T.H. Lynge et al.
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cases aged 1–35 years, SADS was the most frequent underlying cause
of death (n = 7, 54%), while coronary artery disease (n = 16, 64%)
was most common among cases aged 36–49 years. Of the 38 autop-
sied SCD-DM cases, 22 (58%) were examined toxicologically. In 2 of
these 22 cases, findings of illicit drugs were reported (both cocaine).
Incidence rates
Sudden cardiac death IR according to age in persons with and without
DM are shown in Figure 3, while age- and sex-stratified IR are shown
in Table 2. The age- and sex-standardized IR of SCD in persons with
DM aged 1–35 years was 21.9 (95% CI 14.9–72.5) per 100 000
person-years compared to 2.6 (95% CI 2.4–2.8) per 100 000 person-
years in persons aged 1–35 years without DM. This corresponds to
an IR ratio of 8.6 (95% CI 5.8–28.6). Among persons with DM aged
36–49 years, the IR of SCD was 119.8 (95% CI 93.7–152.1) per
100 000 person-years, while the IR of SCD among persons aged 36–
49 years without DM was 19.7 (95% CI 18.2–21.2) corresponding to
an IR ratio of 6.1 (95% CI 4.7–7.8).
Type 1 and 2 diabetes mellitus
Compared to persons with DM1, persons with DM2 were older at
time of SCD (P = 0.036) and more often had psychiatric comorbid-
ities (P = 0.047) (Supplementary material online, Table S1). Duration
of antidiabetic therapy was calculated as time from first redeemed
antidiabetic agent to time of death or end of observational period.
According to information from The Danish National Patient Register
(capturing 90% of the SCD-DM cases in the study) median duration
of DM was 13.9 years for persons with DM1 and 3.9 years for per-
sons with DM2.
Sudden cardiac death was the leading cause of death among per-
sons with DM2, while the most common causes of death among per-
sons with DM1 were endocrine disease (n = 79, 17%) and non-SCD
(n = 78, 17%) (Figure 2). Most common cause of SCD in autopsied
cases was coronary artery disease for both persons with DM1 and
DM2, (n = 11, 42% and n = 7, 58%, respectively), while this was close-
ly followed by SADS among persons with DM1 (n = 7, 31%).
Age- and sex-standardized IR of SCD for persons with DM1 aged
1–35 years was 25.1 (16.3–76.1) per 100 000 person-years and 180.7
(95% CI 130.5–247.3) among persons aged 36–49 years. The IR ratios
between persons with DM1 and without DM were 9.9 (95% CI 6.3–
30) for persons aged 1–35 years and 9.2 (95% CI 6.6–12.7) for per-
sons aged 36–49 years.
Age- and sex-standardized IR of SCD for persons with DM2 aged
21–35 years was 26.7 (95% CI 9.7–150.1) per 100 000 person-years
and 92.4 (95% CI 62.7–135.2) among persons aged 36–49 years. The
IR ratios between persons with DM2 and without DM were 6.1 (95%
Figure 3 Incidence of sudden cardiac death according to age
among persons with and without diabetes mellitus. Vertical bars
represent 95% confidence intervals. DM, diabetes mellitus; DM1,
diabetes mellitus type 1; DM2, diabetes mellitus type 2.
.................................. ......................................................................... ........................................................................
....................................................................................................................................................................................................................
Table 2 Annual incidence rates of sudden cardiac death per 100 000 person-years stratified by age and sex
Age
(years)
Non-DM DM1 DM2
Number
of deaths
IR/100 000
PY
Number
of deaths
IR/100 000
PY
IR ratioc
(95% CI)
P-valuea Number
of deaths
IR/100 000
PY
IR ratiod
(95% CI)
P-valueb
Males 1–10 31 0.9 0 — — — 0 — — —
11–20 57 1.8 <3 10.5 5.9 (0.1–34.4) 0.315 0 — — —
21–30 154 4.6 7 46.3 10.2 (4–21.5) <0.001 0 — — —
31–40 258 10.1 14 90.5 9 (4.8–15.4) <0.001 5 73.4 7.3 (2.3–17.2) 0.002
41–49 391 36.5 29 325.9 8.9 (5.9–13) <0.001 28 143 3.9 (2.6–5.7) <0.001
Females 1–10 16 0.5 0 — — — 0 — — —
11–20 34 1.1 <3 12.1 10.9 (0.3–65.1) 0.180 0 — — —
21–30 72 2.2 7 61.1 28.2 (10.9–61.1) <0.001 <3 12.8 5.9 (0.1–33.9) 0.315
31–40 92 3.7 4 37.6 10.2 (2.7–27) 0.002 6 51.3 13.9 (5–31.5) <0.001
41–49 140 13.3 8 141.8 10.6 (4.5–21.5) <0.001 7 48.7 3.6 (1.4–7.7) 0.008
DM, diabetes mellitus; IR, incidence rate; PY, person-years.
aP-value for differences between persons with DM1 and persons without DM.
bP-value for differences between persons with DM2 and persons without DM.
cIncidence rate ratio between persons with DM1 and persons without DM.
dIncidence rate ratio between persons with DM2 and persons without DM.
SCD among young persons with diabetes 2703
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CI 2.2–34.5) for persons aged 21–35 years and 4.7 (95% CI 3.2–6.9)
for persons aged 36–49 years.
Discussion
Using autopsy reports, death certificates, discharge summaries, and
information from nationwide health registries, we have conducted a
comprehensive nationwide study on SCD among persons with DM
aged 1–49 years.
Autopsy of sudden cardiac death cases
with diabetes
We found lower rates of both medicolegal external examination and
autopsy among SCD-DM cases compared to non-DM SCD cases.
A large proportion of autopsied SCD-DM was, however, caused by
potentially inherited heart conditions such as SADS. Identification of
inheritable SCD causes is important to reduce mortality in family
members of SCD victims as appropriate investigations may identify
living relatives with undiagnosed inherited heart disease.16,17 Sudden
arrhythmic death syndrome was found to be a common cause of
SCD-DM. Postmortem genetic testing has been shown to identify a
likely cause of death in 13–35% of SADS cases and detailed cardiac
and genetic investigation of first-degree relatives of SADS victims
have been shown to yield a diagnosis of inherited heart disease in up
to 50% of affected families.18–26 There is accumulating evidence that
hypoglycaemia can cause cardiac dysfunction and sudden death by
hypoglycaemia-induced cardiac arrhythmias and abnormal cardiac
repolarization.4 Since serum glucose level is greatly modified in the
death process and after death, and not examined routinely in sudden
death, we cannot exclude that the underlying mechanism in some of
the autopsy-negative cases is caused by hypoglycaemia and not an
inherited cardiac disease. However, most previous studies have not
excluded DM in the studies of SADS and current literature within
this area shows that in 40% of all SADS cases, there is a monogen-
etic cause or positive findings in the family for primary arrhythmias
such as long QT syndrome and catecholaminergic polymorphic ven-
tricular tachycardia (CPVT).19 The yield of cardiac and genetic investi-
gation of relatives of SCD-DM victims is, however, not known.
Taken together this supports use of autopsy in all cases of sudden
and unexpected death among young persons, including persons
with DM.
Incidence rates of sudden cardiac death
in persons with diabetes
Previous studies have shown that persons with DM have a two- to
four-fold increased risk of SCD compared to persons without
DM.2,5,6This finding is consistent across studies with different study
design and/or geographical settings.2,5,6 These studies have either
been regional or been conducted in selected populations (e.g. only
autopsied cases). Our study is the first to describe nationwide IR of
SCD among persons with DM in an unselected and young popula-
tion. We found that persons with DM had significantly higher SCD
rates compared to persons without DM with IR ratios of9 and6
in persons aged 1–35 and 36–49 years, respectively.
The discrepancy in IR ratios is likely in part explained by age differ-
ences in the populations studied.2,5,6 Sudden cardiac death IR in a
young and presumably healthy background population is low and
therefore the increased IR of SCD in persons with DM has a greater
impact when examining younger age. Furthermore, this was a retro-
spective nationwide population-based study and we were not able to
adjust for known risk factors for SCD, as done by previous prospect-
ive or case control studies in selected cohorts.2 In the present study,
non-autopsied cases of sudden death were also included, which nat-
urally leads to higher IR compared to studies that only include autop-
sied SCD. Finally, the method we used to identify persons with DM
has a high sensitivity, enabling us to capture most SCD-DM cases.27,28
Cause of death among persons with
diabetes
In line with previous studies, we found cardiovascular disease to be
the most common cause of death among persons with DM.1,29,30
Take home figure Identification and characterization of young persons with diabetes mellitus suffering sudden cardiac death in Denmark. DM,
diabetes mellitus; SCD, sudden cardiac death.
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In studies of causes of death among persons with DM, cardiovascular
disease is rarely divided into SCD and non-SCD.
An Australian-based review of causes of death from 1914 coronial
postmortem examinations in young Australians with DM1, found the
three predominant causes of death among persons <40 years to be
unnatural death (28%), acute complications of diabetes (27%), and
sudden unexpected death (22%).31 Two-thirds of the sudden unex-
pected deaths were attributed to the so-called ‘dead-in-bed’ syn-
drome. Dead-in-bed was defined as a death in a generally well
individual with DM1 that suffers unwitnessed sudden unexpected
death in an undisturbed bed and where autopsy provides no clear
anatomical cause of death.31
The underlying mechanism leading to dead-in-bed syndrome
remains largely unknown, although growing evidence points towards
autonomic neuropathy and nocturnal hypoglycaemia as contributory
causes. Autonomic neuropathy among persons with DM can cause
reduced parasympathetic activity and, in some cases, eventually lead
to sympathetic predominance. Normally at night, the sympathetic re-
sponse is low and parasympathetic activity is relatively high. With
chronic hyperglycaemia resulting in damage to the parasympathetic
system, persons with DM can develop increased mean heart rate and
reduction in diurnal heart rate variation.31 Furthermore, the dead-in-
bed syndrome is believed to be caused by nocturnal arrhythmia pro-
moted by hypoglycaemia, which causes QTc lengthening.
Hypokalaemia due to over-insulinization and adrenaline response
may also play a role.31,32
In the present study, we found 10 SADS cases of which 6 had DM1
and was found dead-in-bed. This corresponds to a dead-in-bed IR of
6.7 (95% CI 3.0–14.8) per 100 000 person-years. These cases could
potentially be dead-in-bed cases, although information regarding
whether the bed was undisturbed was not available.
Duration of DM among SCD-DM cases was remarkable short,
both among DM1 and DM2. The Danish Register of Medicinal
Product Statistics was, however, established in 1995. Furthermore,
the Danish National Patient Register did not include outpatient con-
tacts until 1995. As many DM patients only have outpatient contact
with the health care system, we likely underestimate DM duration in
some patients.
Cardiovascular mortality in persons with DM1 and DM2 is often
due to accelerated atherosclerosis, ischaemic heart disease, and heart
failure, which are all important risk factors for SCD, independent of
other risk factors.33 However, other mechanisms are also likely in
play.4 As in the background population, persons with DM1 may have
a variety of subclinical cardiac diseases. In these patients, arrhythmia/
cardiac arrest may be triggered by severe metabolic decompensation
(e.g. severe diabetic ketoacidosis, hypoglycaemia, and/or out-of-
range potassium). In addition, cardiac autonomic neuropathy (CAN)
might explain the increased incidence of SCD among diabetes
patients. CAN is a serious complication of DM which is associated
with five-fold increased risk of cardiovascular mortality, and an
increased frequency of SCD among persons with CAN has been
reported in multiple studies. Cardiac autonomic neuropathy has
been found both among individuals with DM1 and DM2 and in chil-
dren and adults. Risk markers for CAN are age, DM duration, gly-
caemic control, hypertension, and dyslipidemia.5 The study
population in this study is relatively young and consequently we find
more individuals with DM1 than DM2. The duration of DM among
persons with DM1 is more than three times as long compared to per-
sons with DM2, presumably, leading to a higher prevalence of CAN
among the DM1 group.
Increased prevalence of manifest and silent myocardial ischaemia
and QT interval prolongation have been found among persons with
DM with CAN and this partly explains the increased mortality and
higher proportion of deaths attributed to SCD among persons with
DM.5,33
We found that a high proportion of SCD-DM cases claimed pre-
scriptions of proarrhythmic pharmacotherapy prior to death, which
highlights that an increased focus on identification of individuals at
high risk of SCD among patients receiving proarrhythmic drugs is
warranted.
Limitations
We have previously discussed limitations of defining DM status from
the registration of all usage of antidiabetic pharmacotherapy in the
Danish Register of Medicinal Product Statistics.1 In brief, although
using the Danish Register of Medicinal Product Statistics represents a
conservative way of identifying DM patients, this approach has been
shown to capture at least 85% of patients with DM in Denmark and it
has a positive predictive value of 98%.27,28
Non-autopsied cases of sudden unexpected death were included
if death was presumed to be of cardiac origin after thorough review
of all available information. It cannot be excluded that some of these
cases died from non-cardiac causes such as pulmonary embolism or
hypoglycaemia. Non-autopsied sudden death cases with clinical signs
of a non-cardiac cause of death, however, were not classified as SCD.
We were not able to obtain information on life style factors (e.g.
smoking status, body mass index, lipid levels, and diet) and other im-
portant clinical information such as blood glucose values and hemo-
globin A1C (HbA1c).
Conclusion
In this large nationwide study on SCD-DM, persons with DM had
increased SCD rates compared to person without DM with an IR
ratio of 9 in persons aged 1–35 years. Only one-third of the SCD-
DM cases had an autopsy conducted and almost half of these were
autopsy-negative and potentially caused by inherited heart disease or
cardiac arrhythmias induced by diabetes-related complications such
as hypoglycaemia or CAN.
Our study highlights the need for early cardiovascular risk moni-
toring and assessment in young persons with DM. Furthermore, the
findings support use of autopsy in all cases of sudden and unexpected
death aged 1–49 years, including persons with DM.
Supplementary material
Supplementary material is available at European Heart Journal online.
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